FDMT - 4D Molecular Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FDMT is currently covered by 7 analysts with an average price target of $33.3. This is a potential upside of $27.7 (494.64%) from yesterday's end of day stock price of $5.6.

4D Molecular Therapeutics 's activity chart (see below) currently has 12 price targets and 47 ratings on display. The stock rating distribution of FDMT is 94.87% BUY and 5.13% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.21% with an average time for these price targets to be met of 88.43 days.

Highest price target for FDMT is $81, Lowest price target is $15, average price target is $33.3.

Most recent stock forecast was given by MANI FOROOHAR from LEERINK on 13-Jan-2025. First documented stock forecast 05-Jan-2021.

Currently out of the existing stock ratings of FDMT, 37 are a BUY (94.87%), 2 are a HOLD (5.13%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$27

$22.34 (479.40%)

$36

17 days ago
(13-Jan-2025)

7/9 (77.78%)

$22.24 (467.23%)

285

Buy

$36

$31.34 (672.53%)

$36

17 days ago
(13-Jan-2025)

0/15 (0%)

$31.24 (656.30%)

Buy

$15

$10.34 (221.89%)

$40

17 days ago
(13-Jan-2025)

0/5 (0%)

$10.24 (215.13%)

Buy

$39

$34.34 (736.91%)

$40

2 months 16 days ago
(14-Nov-2024)

2/6 (33.33%)

$31.09 (393.05%)

29

Buy

4 months 7 days ago
(23-Sep-2024)

1/3 (33.33%)

$21.48 (204.18%)

104

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FDMT (4D Molecular Therapeutics ) average time for price targets to be met?

On average it took 88.43 days on average for the stock forecasts to be realized with a an average price target met ratio 29.21

Which analyst has the current highest performing score on FDMT (4D Molecular Therapeutics ) with a proven track record?

GEULAH LIVSHITS

Which analyst has the current lower performing score on FDMT (4D Molecular Therapeutics ) with a proven track record?

SALVEEN RICHTER

Which analyst has the most public recommendations on FDMT (4D Molecular Therapeutics )?

Geulah Livshits works at CHARDAN CAPITAL and has 9 price targets and 11 ratings on FDMT

Which analyst is the currently most bullish on FDMT (4D Molecular Therapeutics )?

Salveen Richter with highest potential upside - $76.34

Which analyst is the currently most reserved on FDMT (4D Molecular Therapeutics )?

Josh Schimmer with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?